GLP-1 Weight Loss Doctor NYC
Meet with an experienced W8MD clinician for a personalized evaluation of semaglutide, tirzepatide, Wegovy, Zepbound and other medical weight-loss options—plus dose planning, side-effect guidance and long-term follow-up.
Prescription treatment requires an individualized medical evaluation. A consultation does not guarantee a prescription.
GLP-1 Weight Loss Options in NYC
GLP-1 and related incretin medicines can reduce appetite, increase satiety and support weight loss when combined with nutrition, activity, sleep and medical follow-up. The appropriate product depends on its approved indication, your health history, contraindications, availability, insurance and budget.
Semaglutide
Wegovy is an FDA-approved semaglutide product for chronic weight management in eligible patients. Ozempic contains semaglutide but is approved for type 2 diabetes and certain related risk-reduction indications—not as a weight-loss brand.
Tirzepatide
Zepbound is an FDA-approved tirzepatide product for chronic weight management in eligible patients and for moderate-to-severe obstructive sleep apnea in adults with obesity. Mounjaro contains tirzepatide but is approved for type 2 diabetes.
GLP-1 medicines are not the only choice. Depending on your needs, a clinician may discuss phentermine, Qsymia, Contrave, orlistat or another prescription weight-loss medication. Brand-name and compounded products are not interchangeable; compounded drugs are not FDA-approved or generic versions of approved brands.
How GLP-1 Treatment at W8MD Works
- Medical evaluation: Review weight history, BMI, weight-related conditions, current medicines, prior treatment, allergies and relevant family history.
- Product-specific decision: Identify the exact medication, approved use, source, expected benefits, limitations, insurance requirements and total anticipated cost.
- Nutrition and activity plan: Build practical goals for protein, fluids, fiber, meal structure, movement and resistance exercise to support health while losing weight.
- Dose and side-effect follow-up: Begin and escalate only as clinically appropriate, monitor tolerability and adjust the plan rather than automatically increasing the dose.
- Maintenance planning: Prepare for plateaus, coverage changes, long-term treatment decisions and strategies that help reduce weight regain.
For a detailed overview of visits and follow-up, see the W8MD clinical weight loss program in NYC.
Who May Qualify for GLP-1 Weight-Loss Medication?
Eligibility is individualized. FDA-approved chronic weight-management medicines commonly use BMI thresholds together with weight-related medical conditions, but the exact criteria, age range and contraindications depend on the product’s current prescribing information. Insurance plans may apply additional requirements.
- BMI and weight-related conditions are reviewed rather than relying on weight alone
- Current medications and previous weight-loss treatment are considered
- Pregnancy, pregnancy planning and breastfeeding require specific discussion
- Personal and family endocrine history, pancreatitis and gastrointestinal history are reviewed
- Coverage, affordability and ability to continue follow-up are included in the decision
If you need a broader assessment before considering a specific prescription, begin with physician-supervised NYC medical weight loss.
Affordable GLP-1 Care in Brooklyn
$29.99/week+
When insurance is accepted for a qualifying visit; self-pay programs from $59.99/week+.
$45/week+
When insurance is accepted for a qualifying visit; self-pay programs from $69.99/week+.
Ask for the complete price: what the starting amount includes, which dose and product it covers, whether visits are billed to insurance, whether medication is separate, and how costs may change during dose escalation.
Medical evaluation required. Eligibility, dose, product, pharmacy, shipping, laboratory needs, availability, insurance benefits and total cost vary. “With insurance” refers to qualifying clinical visits and does not guarantee medication coverage or prior-authorization approval. Compounded drugs are not FDA-approved or generic versions of approved brands.
Safety, Side Effects and Follow-Up
Common adverse effects of GLP-1 and related medicines can include nausea, vomiting, diarrhea, constipation and abdominal discomfort. Product labeling also contains important contraindications, warnings and precautions. Risks differ by medication and patient, so online information cannot replace a product-specific medical review.
- Know the exact drug, concentration, dose and pharmacy before using it
- Follow clinician instructions for dose escalation; faster is not necessarily better
- Report persistent vomiting, dehydration, severe abdominal pain or other concerning symptoms promptly
- Tell every treating clinician about GLP-1 use, especially before anesthesia or a procedure
- Do not share prescription medication or obtain it from an unverified source
Patients with snoring, witnessed pauses in breathing or daytime sleepiness can also ask about a sleep apnea evaluation in NYC or a convenient home sleep study.
“Fantastic Program. Truly A Life Changer!”
D.M. — W8MD patient success story
D.M. reported losing approximately 100 pounds and maintaining substantial weight loss for more than ten years. Individual results vary; this experience does not predict another patient’s outcome.
Visit a GLP-1 Doctor at W8MD Brooklyn
W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3Brooklyn, NY 11235
Serving Brooklyn, Queens, Manhattan, the Bronx, Staten Island, Long Island and nearby Greater NYC communities.
Integrated W8MD Care
Medical weight loss, sleep medicine, home sleep studies, IV/IM nutrition and medical aesthetic services are available through the W8MD network.
GLP-1 Doctor NYC: Frequently Asked Questions
Do I need to see a clinician before receiving a GLP-1 prescription?
Yes. Prescription treatment requires an individualized medical evaluation. The clinician must determine whether a specific medication is appropriate; scheduling a consultation does not guarantee a prescription.
Which GLP-1 weight-loss medications does W8MD evaluate?
Depending on eligibility and availability, W8MD may evaluate semaglutide- and tirzepatide-based options, including FDA-approved weight-management brands such as Wegovy and Zepbound, as well as non-GLP-1 medications. The exact product and approved indication matter.
Does W8MD accept insurance for GLP-1 visits?
W8MD accepts many insurance plans for qualifying clinical visits. Participation, benefits, deductibles and copays must be confirmed. Visit coverage does not mean the medication itself is covered.
Can W8MD help with GLP-1 prior authorization?
When coverage exists and a patient meets plan criteria, W8MD may submit supporting documentation and a prior-authorization request. Approval is determined by the insurance plan and is not guaranteed.
Are compounded semaglutide and tirzepatide FDA-approved?
No. Compounded drugs are not FDA-approved, and they are not generic versions of Wegovy or Zepbound. A clinician should clearly identify the exact product, source, limitations, risks and alternatives.
Are GLP-1 weight-loss results guaranteed?
No. Results vary with health status, medication, tolerability, nutrition, activity, sleep, duration of treatment and follow-up. Long-term planning is important because weight regain can occur after treatment changes or discontinuation.
Where is the W8MD GLP-1 clinic in NYC?
W8MD’s New York office is at 2632 East 21st Street, Suite L3, Brooklyn, NY 11235. Call 718-946-5500 for current scheduling.
Request a GLP-1 Consultation in Brooklyn
Ask about appointments, insurance, medical weight loss or related W8MD services. Please do not include sensitive medical, payment or insurance identifiers.
Leave a Reply